A single test for comprehensive pathogen diagnostics
Problems we solve
Current gold standard for infectious disease diagnostics relies on antiquated technologies which yield inconsistent results.
BIOTIA-ID is an NGS platform utilizing a database of more than 7,000 pathogens to accurately and sensitively diagnose infectious disease causing pathogens.
With a quick turn around time of 36-48 hours, we can provide you the rapid answers you need to provide the best care possible to your patients.
Biotia-ID utilizes next-generation sequencing (NGS) to be able to accurately and consistently identify pathogens known to cause an array of diseases.
BIOTIA-ID identifies antimicrobial resistance markers to improve clinical therapeutic decisions a patient health outcome.
With a rapidly evolving database of over 7,000 pathogens Biotia-ID is able to identify and flag emerging species that may be on the rise in a certain sample time.
BIOTIA‑ID key features
Continuous database, bioinformatic and ML/AI development
Learn more about our products
BIOTIA-ID for Urinary Tract Infection
BIOTIA-ID Urine Assay allows for comprehensive, sensitive, and accurate detection of urogenital pathogens.
BIOTIA-ID for Joint Infections
BIOTIA-ID Sterile Fluid Assay allows for comprehensive, sensitive, and accurate detection of key pathogens.
Collaborators & partners
Biotia has extensive experience leading clinical and research development in infectious disease diagnostics and pathogen surveillance.
We are proud of our extensive network and clinical partners ranging from prestigious academic institutions and medical centers, clinics, health organizations to physician groups.
"Improve patient outcomes and reduce hospital costs with one single test."